We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BioFocus DPI Launches Five new Compound Libraries
Product News

BioFocus DPI Launches Five new Compound Libraries

BioFocus DPI Launches Five new Compound Libraries
Product News

BioFocus DPI Launches Five new Compound Libraries


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "BioFocus DPI Launches Five new Compound Libraries"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Five novel hit-finding compound libraries targeting the ion channel gene family have been released by BioFocus DPI. Created using advanced modeling tools, these new libraries are specifically aimed at voltage-dependent and ligand-gated channels, two of the most important and commonly chosen classes of ion channels for drug discovery.

The three new SoftFocus Ion Channel (SFI) libraries target voltage-dependent channels, primarily focusing on sodium and calcium channels to complement BioFocus DPI’s earlier libraries focused on potassium channels. These libraries were designed using BioFocus DPI’s proprietary chemogenomic tool Helical Domain Recognition Analysis.

The two new FieldFocus libraries target members of the transient receptor potential (TRP) channel, including TPRV, TRPM and TRPAs, and were created in collaboration with Cresset BioMolecular’s FieldPrint technology.

The compounds within these five new ion channel libraries have physicochemical properties, making them ideal starting points in hit-to-lead programs. Furthermore, synthetic procedures have been developed, which will help facilitate rapid hit follow-up.

“Our entire design and synthesis process is driven by the fundamental belief that drug discovery will be more successful by starting with novel molecules designed to selectively interact with distinct gene families,” said Phil Dudfield, VP Discovery Products, BioFocus DPI. “This approach results in the outstanding success that our compound libraries have delivered for our partners’ drug discovery programs.”

Advertisement